title: Mesenchymal stem cell transplantation may provide a new therapy for ultrafiltration failure in chronic peritoneal dialysis.
abstract: BACKGROUND
  The purpose of this study was to investigate possible healing effects of intraperitoneal (IP) mesenchymal stem cell (MSC) transplantation on ultrafiltration failure (UFF) in a chronic rat model of peritoneal dialysis (PD).
  
  
  METHODS
  Rats were initially divided into two groups. The APUF group received once-daily IP injections of 20 mL of 3.86% glucose PD solution for 6 weeks to stimulate the development of UFF and a control group received noinjections. The PUF group was sub-divided into three groups: a PUF-C group, an MSC group and a Placebo (P) group. Peritoneal equilibration tests (PETs) and peritoneal biopsies were performed in the control and PUF-C groups. MSCs were administered by IP injection in the MSC group and the PUF-C and P groups received IP injection of placebo. PETs and peritoneal biopsies were performed in the MSC and P groups at the first [P-1 (and MSC-1 groups] and second [P-2 and MSC-2 groups] week after receiving MSCs or placebo.
  
  
  RESULTS
  When compared with the control group, ultrafiltration capacity significantly decreased and the submesothelial thickness increased in the PUF-C and P groups (P-1, P-2) (P < 0.05), but there were no differences between the control and MSC groups (MSC-1, MSC-2). The rate of glucose transport was high in the PUF-C and P-2 groups compared with the control group, and D/PCr rates in the PUF-C and P-2 groups were lower than in the control group (P < 0.05). However, D/D0(glucose) was higher and D/P(Cr)was lower in the MSC-2 group than in the PUF-C and P-2 groups (P < 0.05). Transforming growth factor-β (TGF-β) levels were lower in the MSC groups than in the P and PUF-C groups (P < 0.05).
  
  
  CONCLUSIONS
  The PUF-C group had a high permeability UFF. These results showed that MSC transplantation exerted positive effects on UFF in a chronic rat model of PD. MSC transplantation may provide new options for the renewal of the peritoneum in chronic PD patients with UFF.
authors.affiliation: Department of Pediatric Nephrology, Erciyes University Medical Faculty, Kayseri, Turkey.
authors.forename: Funda
authors.initials: F
authors.lastname: Bastug
authors.forename: Zübeyde
authors.initials: Z
authors.lastname: Gündüz
authors.forename: Sebahat
authors.initials: S
authors.lastname: Tülpar
authors.forename: Yasemin Altuner
authors.initials: YA
authors.lastname: Torun
authors.forename: Hülya
authors.initials: H
authors.lastname: Akgün
authors.forename: Erman
authors.initials: E
authors.lastname: Dörterler
authors.forename: Ruhan
authors.initials: R
authors.lastname: Düsünsel
authors.forename: Hakan
authors.initials: H
authors.lastname: Poyrazoglu
authors.forename: Osman
authors.initials: O
authors.lastname: Bastug
authors.forename: Ismail
authors.initials: I
authors.lastname: Dursun
authors.forename: Sibel
authors.initials: S
authors.lastname: Yel
mesh_terms: D000818:Animals; D001692:Biological Transport; D002463:Cell Membrane Permeability; D002908:Chronic Disease; D015314:Dialysis Solutions; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010537:Peritoneum / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D016212:Transforming Growth Factor beta / Q000378:metabolism; D017211:Treatment Failure; D014462:Ultrafiltration / Q000009:adverse effects*
chemical_list: D015314:Dialysis Solutions; D016212:Transforming Growth Factor beta
keywords: chronic peritoneal dialysis; mesenchymal stem cell transplantation; ultrafiltration failure